199 related articles for article (PubMed ID: 19938224)
21. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
22. [Antiviral effects of the combination of glycyrrhizin and ribavirin against influenza A H1N1 virus infection in vivo].
Chen XX; Zhou HX; Qi WB; Ning ZY; Ma YJ; Li YL; Wang GC; Chen JX
Yao Xue Xue Bao; 2015 Aug; 50(8):966-72. PubMed ID: 26668995
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of recombinant manganese superoxide dismutase on influenza virus infections in mice.
Sidwell RW; Huffman JH; Bailey KW; Wong MH; Nimrod A; Panet A
Antimicrob Agents Chemother; 1996 Nov; 40(11):2626-31. PubMed ID: 8913477
[TBL] [Abstract][Full Text] [Related]
24. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "sho-seiryu-to"--stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice.
Nagai T; Yamada H
Immunopharmacol Immunotoxicol; 1998 May; 20(2):267-81. PubMed ID: 9653672
[TBL] [Abstract][Full Text] [Related]
25. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
Li L; Yu CH; Ying HZ; Yu JM
J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of Yinhuapinggan granule on mice with influenza viral pneumonia.
Peng XQ; Zhou HF; Lu YY; Chen JK; Wan HT; Zhang YY
Int Immunopharmacol; 2016 Jan; 30():85-93. PubMed ID: 26655878
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and mechanism of action of yin lai tang (lung-stomach treatment) in dyspepsia mouse infected by FM1 virus.
Liu T; Yu H; Zhang W; Zhen J; Li X; Lv G; Gu HX; Murtaza G
Acta Pol Pharm; 2013; 70(6):1107-15. PubMed ID: 24383334
[TBL] [Abstract][Full Text] [Related]
28. [The expression of the inflammation-related cytokines in pneumonia mice infected with influenza virus and regulation of Shufengxuanfei and Jiebiaoqingli herbal anti-virus formulas].
Lu N; Liu Q; Gu L; Wu J; Qiu Z; Zhang H; Chao E; Zhang Y; Yu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Mar; 30(3):254-7. PubMed ID: 24606741
[TBL] [Abstract][Full Text] [Related]
29. Anti-H1N1 influenza effects and its possible mechanism of Huanglian Xiangru Decoction.
Wu QF; Zhu WR; Yan YL; Zhang XX; Jiang YQ; Zhang FL
J Ethnopharmacol; 2016 Jun; 185():282-8. PubMed ID: 26940899
[TBL] [Abstract][Full Text] [Related]
30. [Effects of Tankejing dry powder inhaler on the inflammatory damage in the lungs of mice infected by FM1].
Jiang YN; Mo HY
Zhong Yao Cai; 2009 Jul; 32(7):1093-7. PubMed ID: 19873739
[TBL] [Abstract][Full Text] [Related]
31. Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.
Hsieh CF; Lo CW; Liu CH; Lin S; Yen HR; Lin TY; Horng JT
J Ethnopharmacol; 2012 Aug; 143(1):57-67. PubMed ID: 22710290
[TBL] [Abstract][Full Text] [Related]
32. Small-particle aerosols of antiviral compounds in treatment of type A influenza pneumonia in mice.
Walker JS; Stephen EL; Spertzel RO
J Infect Dis; 1976 Jun; 133 Suppl():A140-4. PubMed ID: 932501
[TBL] [Abstract][Full Text] [Related]
33. [Effect of baicalin on in vivo anti-virus].
Chu ZY; Chu M; Teng Y
Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2413-5. PubMed ID: 18257272
[TBL] [Abstract][Full Text] [Related]
34. Chemical compositions and anti-influenza activities of essential oils from Mosla dianthera.
Wu QF; Wang W; Dai XY; Wang ZY; Shen ZH; Ying HZ; Yu CH
J Ethnopharmacol; 2012 Jan; 139(2):668-71. PubMed ID: 22193174
[TBL] [Abstract][Full Text] [Related]
35. In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system.
Yamada H; Nagai T
Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):185-92. PubMed ID: 9646280
[TBL] [Abstract][Full Text] [Related]
36. Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice.
Chen L; Dou J; Su Z; Zhou H; Wang H; Zhou W; Guo Q; Zhou C
Antiviral Res; 2011 Sep; 91(3):314-20. PubMed ID: 21782851
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.
Shi XL; Shi ZH; Huang H; Zhu HG; Zhou P; Ju D
Inflammation; 2010 Jun; 33(3):166-72. PubMed ID: 19957025
[TBL] [Abstract][Full Text] [Related]
38. ESR evidence for in vivo formation of free radicals in tissue of mice exposed to single-walled carbon nanotubes.
Shvedova AA; Kisin ER; Murray AR; Mouithys-Mickalad A; Stadler K; Mason RP; Kadiiska M
Free Radic Biol Med; 2014 Aug; 73():154-65. PubMed ID: 24863695
[TBL] [Abstract][Full Text] [Related]
39. Oxyradicals under UV-b stress and their quenching by antioxidants.
Jain K; Kataria S; Guruprasad KN
Indian J Exp Biol; 2004 Sep; 42(9):884-92. PubMed ID: 15462181
[TBL] [Abstract][Full Text] [Related]
40. [Effects of Dureping Injection on the contents of MMP-9 and TIMP-1 in the lung tissue of mice with pneumonia of influenza virus infection].
Qi GJ; Gu LG; Peng GY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Nov; 31(11):1510-3. PubMed ID: 22303715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
